Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.
Tarral A, Blesson S, Mordt OV, Torreele E, Sassella D, Bray MA, Hovsepian L, Evène E, Gualano V, Felices M, Strub-Wourgaft N. Tarral A, et al. Among authors: evene e. Clin Pharmacokinet. 2014 Jun;53(6):565-80. doi: 10.1007/s40262-014-0136-3. Clin Pharmacokinet. 2014. PMID: 24535888 Free PMC article. Clinical Trial.
Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers.
Ribeiro I, Blum B, Fernandes J, Santina G, Asada M, Everson M, Schuck E, Feleder E, Evene E, Gualano V. Ribeiro I, et al. Among authors: evene e. Antimicrob Agents Chemother. 2021 Mar 18;65(4):e02150-19. doi: 10.1128/AAC.02150-19. Print 2021 Mar 18. Antimicrob Agents Chemother. 2021. PMID: 33558286 Free PMC article.
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.
Tranchand B, Catimel G, Lucas C, Sarkany M, Bastian G, Evene E, Guastalla JP, Négrier S, Rebattu P, Dumortier A, Foy M, Grossin F, Mazier B, Froudarakis M, Barbet N, Clavel M, Ardiet C. Tranchand B, et al. Among authors: evene e. Cancer Chemother Pharmacol. 1998;41(4):281-91. doi: 10.1007/s002800050741. Cancer Chemother Pharmacol. 1998. PMID: 9488597 Clinical Trial.
A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
Chassard D, Kanis R, Namour F, Evene E, Ntssikoussalabongui B, Schmitz V. Chassard D, et al. Among authors: evene e. J Dermatolog Treat. 2006;17(3):154-7. doi: 10.1080/09546630600727115. J Dermatolog Treat. 2006. PMID: 16854755 Free article. Clinical Trial.
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Dirix L, Catimel G, Koier I, Provè A, Schrijvers D, Joossens E, De Bruijn E, Ardiet C, Evene E, Dumortier A, et al. Dirix L, et al. Among authors: evene e. Anticancer Drugs. 1995 Feb;6(1):53-63. doi: 10.1097/00001813-199502000-00006. Anticancer Drugs. 1995. PMID: 7756684 Clinical Trial.
11 results